Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 13 de 13
Filter
Add more filters










Publication year range
1.
Biotechnol Prog ; 23(2): 435-43, 2007.
Article in English | MEDLINE | ID: mdl-17256966

ABSTRACT

Multigene expression vectors are commonly utilized whereby the (over)expression of two or more genes is desired simultaneously and often at supposedly equivalent levels. We have characterized dual-gene and pEE14.4 RlucMFluc expression plasmids in which the second hCMV-MIE promoter is replaced with a c-myc IRES to enable one-step coordinated expression of multiple genes in eukaryotic cells. The efficacy of these plasmids has been tested in Chinese hamster ovary (CHO) cells using renilla and firefly luciferase reporter genes, with the reporter gene in either position 1 or 2 from the 5' to 3' direction, respectively. The dual-gene constructs gave enhanced second position gene expression levels compared to the first gene during transient transfection experiments (4- to 50-fold increase 24 h post-transfection). The pEE14.4 RlucMFluc plasmid gave enhanced first cistron expression compared to the second cistron ( approximately 19-fold increase 24 h post-transfection). More equivalent transient expression levels were obtained by undertaking co-transfection of the appropriate single gene plasmids. Reporter gene mRNA levels in the transfected cells were also evaluated by qRT-PCR and compared to the observed protein expression levels. Analysis of the resulting data showed that transcriptional limitation of the first cistron in the dual-gene expression system and not translational limitation was the major limiting factor. Taken together these data suggest that relative protein expression levels expected from heterologous gene products in a multigene vector cannot be predicted on copy number alone and it is important to characterize multigene or oligocistronic systems prior to use.


Subject(s)
Gene Expression/genetics , Genetic Engineering/methods , Genetic Vectors/genetics , Multigene Family/genetics , Promoter Regions, Genetic/genetics , Recombinant Fusion Proteins/biosynthesis , Recombinant Fusion Proteins/genetics , Animals , CHO Cells , Cricetinae , Cricetulus
2.
Biotechnol Bioeng ; 97(2): 410-24, 2007 Jun 01.
Article in English | MEDLINE | ID: mdl-17115445

ABSTRACT

In this study we have analyzed the dynamic covariation of the mammalian cell proteome with respect to functional phenotype during fed-batch culture of NS0 murine myeloma cells producing a recombinant IgG(4) monoclonal antibody. GS-NS0 cells were cultured in duplicate 10 L bioreactors (36.5 degrees C, 15% DOT, pH 7.0) for 335 h and supplemented with a continuous feed stream after 120 h. Cell-specific growth rate declined continuously after 72 h of culture. Cell-specific recombinant monoclonal antibody production rate (qP) varied sixfold through culture. Whilst qP correlated with relative recombinant heavy chain mRNA abundance up to 216 h, qP subsequently declined, independent of recombinant heavy chain or light chain mRNA abundance. GS-NS0 cultures were sampled at 48 h intervals between 24 and 264 h of culture for proteomic analyses. Total protein abundance and nascent polypeptide synthesis was determined by 2D PAGE of unlabeled proteins visualized by SYPRO Ruby and autoradiography of (35)S-labeled polypeptides, respectively. Covariation of nascent polypeptide synthesis and abundance with biomass-specific cell growth, glucose and glutamate consumption, lactate and Mab production rates were then examined using two partial least squares regression models. Most changes in polypeptide synthesis or abundance for proteins previously identified by mass spectrometry were positively correlated with biomass-specific growth rate. We conclude that the substantial transitions in cell physiology and qP that occur during culture utilize a relatively constant complement of the most abundant host cell machines that vary primarily with respect to induced changes in cell growth rate.


Subject(s)
Antibodies, Monoclonal/biosynthesis , Multiple Myeloma/metabolism , Protein Engineering/methods , Animals , Antibodies, Monoclonal/genetics , Bioreactors , Cell Culture Techniques , Cell Line, Tumor , Mice , Recombinant Proteins/biosynthesis
3.
Adv Drug Deliv Rev ; 58(5-6): 671-85, 2006 Aug 07.
Article in English | MEDLINE | ID: mdl-16822577

ABSTRACT

The clinical and commercial success of monoclonal antibodies has led to the need for very large-scale production in mammalian cell culture. This has resulted in rapid expansion of global manufacturing capacity [1], an increase in size of reactors (up to 20,000 L) and a greatly increased effort to improve process efficiency with concomitant manufacturing cost reduction. This has been particularly successful in the upstream part of the process where productivity of cell cultures has improved 100 fold in the last 15 years. This success has resulted from improvements in expression technology and from process optimisation, especially the development of fed-batch cultures. In addition to improving process/cost efficiencies, a second key area has been reducing the time taken to develop processes and produce the first material required for clinical testing and proof-of-principle. Cell line creation is often the slowest step in this stage of process development. This article will review the technologies currently used to make monoclonal antibodies with particular emphasis on mammalian cell culture. Likely future trends are also discussed.


Subject(s)
Antibodies, Monoclonal/biosynthesis , Antibodies, Monoclonal/genetics , Protein Engineering , Animals , Antibodies, Monoclonal/economics , Cell Line , Drug Industry , Genetic Vectors , Humans , Transcription, Genetic
4.
Biochim Biophys Acta ; 1764(7): 1179-87, 2006 Jul.
Article in English | MEDLINE | ID: mdl-16807148

ABSTRACT

We have undertaken two-dimensional gel electrophoresis proteomic profiling on a series of cell lines with different recombinant antibody production rates. Due to the nature of gel-based experiments not all protein spots are detected across all samples in an experiment, and hence datasets are invariably incomplete. New approaches are therefore required for the analysis of such graduated datasets. We approached this problem in two ways. Firstly, we applied a missing value imputation technique to calculate missing data points. Secondly, we combined a singular value decomposition based hierarchical clustering with the expression variability test to identify protein spots whose expression correlates with increased antibody production. The results have shown that while imputation of missing data was a useful method to improve the statistical analysis of such data sets, this was of limited use in differentiating between the samples investigated, and highlighted a small number of candidate proteins for further investigation.


Subject(s)
Algorithms , Proteome/analysis , Proteomics/statistics & numerical data , Animals , Antibodies, Monoclonal/biosynthesis , Antibodies, Monoclonal/genetics , Cell Line, Tumor , Cluster Analysis , Electrophoresis, Gel, Two-Dimensional , Glutamate-Ammonia Ligase/biosynthesis , Glutamate-Ammonia Ligase/genetics , Image Processing, Computer-Assisted , Principal Component Analysis , Proteomics/methods , Recombinant Proteins/genetics , Recombinant Proteins/metabolism
5.
Biotechnol Prog ; 22(3): 753-62, 2006.
Article in English | MEDLINE | ID: mdl-16739959

ABSTRACT

In this study we describe optimization of polyethylenimine (PEI)-mediated transient production of recombinant protein by CHO cells by facile manipulation of a chemically defined culture environment to limit accumulation of nonproductive cell biomass, increase the duration of recombinant protein production from transfected plasmid DNA, and increase cell-specific production. The optimal conditions for transient transfection of suspension-adapted CHO cells using branched, 25 kDa PEI as a gene delivery vehicle were experimentally determined by production of secreted alkaline phosphatase reporter in static cultures and recombinant IgG4 monoclonal antibody (Mab) production in agitated shake flask cultures to be a DNA concentration of 1.25 microg 10(6) cells(-1) mL(-1) at a PEI nitrogen:DNA phosphate ratio of 20:1. These conditions represented the optimal compromise between PEI cytotoxicity and product yield with most efficient recombinant DNA utilization. Separately, both addition of recombinant insulin-like growth factor (LR3-IGF) and a reduction in culture temperature to 32 degrees C were found to increase product titer 2- and 3-fold, respectively. However, mild hypothermia and LR3-IGF acted synergistically to increase product titer 11-fold. Although increased product titer in the presence of LR3-IGF alone was solely a consequence of increased culture duration, a reduction in culture temperature post-transfection increased both the integral of viable cell concentration (IVC) and cell-specific Mab production rate. For cultures maintained at 32 degrees C in the presence of LR3-IGF, IVC and qMab were increased 4- and 2.5-fold, respectively. To further increase product yield from transfected DNA, the duration of transgene expression in cell populations maintained at 32 degrees C in the presence of LR3-IGF was doubled by periodic resuspension of transfected cells in fresh media, leading to a 3-fold increase in accumulated Mab titer from approximately 13 to approximately 39 mg L(-1). Under these conditions, Mab glycosylation at Asn297 remained essentially constant and similar to that of the same Mab produced by stably transfected GS-CHO cells. From these data we suggest that the efficiency of transient production processes (protein output per rDNA input) can be significantly improved using a combination of mild hypothermia and growth factor(s) to yield an extended "activated hypothermic synthesis".


Subject(s)
Antibodies, Monoclonal/biosynthesis , Polyethyleneimine/chemistry , Alkaline Phosphatase/biosynthesis , Alkaline Phosphatase/metabolism , Animals , Antibodies, Monoclonal/drug effects , Antibodies, Monoclonal/genetics , CHO Cells , Cell Culture Techniques/methods , Cells, Cultured , Cricetinae , Culture Media, Conditioned/pharmacology , DNA/chemistry , DNA/metabolism , DNA/pharmacokinetics , Gene Expression/drug effects , Gene Transfer Techniques , Immunoglobulin G/biosynthesis , Immunoglobulin G/drug effects , Plasmids/chemistry , Plasmids/metabolism , Polyethyleneimine/pharmacology , Recombinant Proteins/biosynthesis , Recombinant Proteins/drug effects , Substrate Specificity , Time Factors
6.
Biotechnol Bioeng ; 94(5): 830-41, 2006 Aug 05.
Article in English | MEDLINE | ID: mdl-16489627

ABSTRACT

We previously compared changes in individual protein abundance between the proteomes of GS-NS0 cell lines with varying rates of cell-specific recombinant monoclonal antibody production (qMab). Here we extend analyses of our proteomic dataset to statistically determine if particular cell lines have distinct functional capabilities that facilitate production of secreted recombinant Mab. We categorized 79 proteins identified by mass spectrometry according to their biological function or location in the cell and statistically compared the relative abundance of proteins in each category between GS-NS0 cell lines with varying qMab. We found that the relative abundance of proteins in ER chaperone, non-ER chaperone, cytoskeletal, cell signaling, metabolic, and mitochondrial categories were significantly increased with qMab. As the GS-NS0 cell line with highest qMab also had an increased intracellular abundance of unassembled Mab heavy chain (HC), we tested the hypothesis that the increased ER chaperone content was caused by induction of an unfolded protein response (UPR) signaling pathway. Immunoblot analyses revealed that spliced X-box binding protein 1 (XBP1), a marker for UPR induction, was not detectable in the GS-NS0 cells with elevated qMab, although it was induced by chemical inhibitors of protein folding. These data suggest that qMab is functionally related to the abundance of specific categories of proteins that together facilitate recombinant protein production. We infer that individual cells within parental populations are more functionally equipped for high-level recombinant protein production than others and that this bias could be used to select cells that are more likely to achieve high qMab.


Subject(s)
Antibodies, Monoclonal/biosynthesis , Antibodies, Monoclonal/genetics , Multiple Myeloma/classification , Multiple Myeloma/metabolism , Myeloma Proteins/metabolism , Protein Engineering/methods , Proteome/metabolism , Animals , Cell Line, Tumor , Cell Proliferation , Gene Expression Regulation, Neoplastic , Mice , Mitochondrial Proteins/metabolism , Recombinant Proteins/biosynthesis
7.
Proteomics ; 5(18): 4689-704, 2005 Dec.
Article in English | MEDLINE | ID: mdl-16247733

ABSTRACT

The folding, transport and modification of recombinant proteins in the constitutive secretory pathway of eukaryotic cell expression systems are reported to be a bottleneck in their production. We have utilised a proteomic approach to investigate the processes catalysed by proteins constituting the secretory pathway to further our understanding of those processes involved in high-level antibody secretion. We used GS-NS0 cell populations differing in qmAb to prepare enriched microsome fractions from each cell population at mid-exponential growth phase. These were analysed by 2-D PAGE to characterise the microsome protein component and test the hypothesis that bottlenecks in recombinant protein synthesis exist in these compartments, which are alleviated in high producers by the up-regulation of key secretory pathway proteins. Proteins whose abundance changed in a statistically significant manner with increasing qmAb were involved in a range of cellular functions: energy metabolism, mAb folding/assembly, cytoskeletal organisation and protein turnover. Amongst these were BiP and PDI, chaperones resident in the ER that interact with nascent immunoglobulins during their folding/assembly. However, our results suggest that there are diverse mechanisms by which these cells achieve qmAb. The results imply that cell-engineering strategies for improving qmAb should target proteins associated with altered functional phenotype identified in this study.


Subject(s)
Antibodies, Monoclonal/biosynthesis , Gene Expression Profiling/methods , Proteome/metabolism , Recombinant Proteins/biosynthesis , Animals , Antibodies, Monoclonal/genetics , Cell Line, Tumor , Electrophoresis, Gel, Two-Dimensional , Gene Expression Regulation, Neoplastic , Glutamate-Ammonia Ligase/biosynthesis , Glutamate-Ammonia Ligase/genetics , Mice , Microsomes/metabolism , Multiple Myeloma/metabolism , Recombinant Proteins/genetics
9.
Biotechnol Prog ; 21(1): 122-33, 2005.
Article in English | MEDLINE | ID: mdl-15903249

ABSTRACT

Monoclonal antibodies (Mab) are heterotetramers consisting of an equimolar ratio of heavy chain (HC) and light chain (LC) polypeptides. Accordingly, most recombinant Mab expression systems utilize an equimolar ratio of heavy chain (hc) to light chain (lc) genes encoded on either one or two plasmids. However, there is no evidence to suggest that this gene ratio is optimal for stable or transient production of recombinant Mab. In this study we have determined the optimal ratio of hc:lc genes for production of a recombinant IgG4 Mab, cB72.3, by Chinese hamster ovary (CHO) cells using both empirical and mathematical modeling approaches. Polyethyleneimine-mediated transient expression of cB72.3 at varying ratios of hc:lc genes encoded on separate plasmids yielded an optimal Mab titer at a hc:lc gene ratio of 3:2; a conclusion confirmed by separate mathematical modeling of the Mab folding and assembly process using transient expression data. On the basis of this information, we hypothesized that utilization of hc genes at low hc:lc gene ratios is more efficient. To confirm this, cB72.3 Mab was transiently produced by CHO cells at constant hc and varying lc gene dose. Under these conditions, Mab yield was increased with a concomitant increase in lc gene dose. To determine if the above findings also apply to stably transfected CHO cells producing recombinant Mab, we compared the intra- and extracellular ratios of HC and LC polypeptides for three GS-CHO cells lines transfected with a 1:1 ratio of hc:lc genes and selected for stable expression of the same recombinant Mab, cB72.3. Intra- and extracellular HC:LC polypeptide ratios ranged from 1:2 to 1:5, less than that observed on transient expression of the same Mab in parental CHO cells using the same vector. In conclusion, our data suggest that the optimal ratio of hc:lc genes used for transient and stable expression of Mab differ. In the case of the latter, we infer that optimal Mab production by stably transfected cells represents a compromise between HC abundance limiting productivity and the requirement for excess LC to render Mab folding and assembly more efficient.


Subject(s)
Antibodies, Monoclonal/biosynthesis , Immunoglobulin Heavy Chains/genetics , Immunoglobulin Light Chains/genetics , Animals , CHO Cells , Cell Culture Techniques/methods , Cells, Cultured , Cricetinae , Culture Media , Culture Media, Serum-Free , Immunoglobulin G/biosynthesis , Models, Theoretical , Peptides/genetics , Recombinant Proteins/biosynthesis , Transfection
10.
Biotechnol Bioeng ; 89(7): 805-14, 2005 Mar 30.
Article in English | MEDLINE | ID: mdl-15688359

ABSTRACT

The perception of environmental stress in animal cells engineered to produce heterologous protein leads to the induction of stress signaling pathways and ultimately apoptosis and cell death. Protein synthesis is regulated in response to various environmental stresses by phosphorylation of the alpha subunit of the eukaryotic initiation factor 2 (eIF2). In this study we have utilized a model system of Chinese hamster ovary cells engineered to secrete recombinant TIMP-1 protein to investigate the relationship between the cellular rate of protein synthesis, eIF2alpha phosphorylation, cellular stress perception, and the rate of cell specific recombinant protein synthesis. The rate of total protein synthesis was maximal after 48 hours of culture, remaining relatively high until 96 hours of culture, after which a decline was observed. Towards the end of culture a marked increase in labeled secreted protein was observed. Total eIF2alpha expression levels were high during the exponential growth phase and decreased slightly towards the end of culture. On the other hand, the relative expression of phosphorylated eIF2alpha showed a bi-phasic response with a small increase in phosphorylated eIF2alpha observed at 48 hours of culture, and a significant increase at 120 hours post-inoculation. The large increase in phosphorylated eIF2alpha coincided with the observed increase in labeled secreted protein and the decline in total cellular protein synthesis. A marked increase in ubiquitination was also observed at 120 hours post-inoculation that coincided with reduced rates of cellular protein synthesis and mRNA translation attenuation. We suggest that eIF2alpha phosphorylation is an indicator of cellular stress perception, which could be exploited in recombinant protein manufacturing to commence feeding and engineering strategies.


Subject(s)
Eukaryotic Initiation Factor-2/metabolism , Gene Expression Regulation , Oxidative Stress , Protein Biosynthesis , Animals , Antibodies, Monoclonal/metabolism , Bioreactors , Blotting, Western , CHO Cells , Cricetinae , Cricetulus , Down-Regulation , Electrophoresis, Polyacrylamide Gel , Eukaryotic Initiation Factor-2/genetics , Fluorescent Antibody Technique, Indirect , Genetic Engineering , Kinetics , Methionine/metabolism , Phosphorylation , Recombinant Proteins/isolation & purification , Recombinant Proteins/metabolism , Silver Staining , Sulfur Radioisotopes/metabolism , Tissue Inhibitor of Metalloproteinase-1/genetics , Tissue Inhibitor of Metalloproteinase-1/isolation & purification , Tissue Inhibitor of Metalloproteinase-1/metabolism , Ubiquitin/metabolism
11.
Biotechnol Bioeng ; 88(6): 707-21, 2004 Dec 20.
Article in English | MEDLINE | ID: mdl-15532040

ABSTRACT

We have developed a simple and robust transient expression system utilizing the 25 kDa branched cationic polymer polyethylenimine (PEI) as a vehicle to deliver plasmid DNA into suspension-adapted Chinese hamster ovary cells synchronized in G2/M phase of the cell cycle by anti-mitotic microtubule disrupting agents. The PEI-mediated transfection process was optimized with respect to PEI nitrogen to DNA phosphate molar ratio and the plasmid DNA mass to cell ratio using a reporter construct encoding firefly luciferase. Optimal production of luciferase was observed at a PEI N to DNA P ratio of 10:1 and 5 mug DNA 10(6) cells(-1). To manipulate transgene expression at mitosis, we arrested cells in G2/M phase of the cell cycle using the microtubule depolymerizing agent nocodazole. Using secreted human alkaline phosphatase (SEAP) and enhanced green fluorescent protein (eGFP) as reporters we showed that continued inclusion of nocodazole in cell culture medium significantly increased both transfection efficiency and reporter protein production. In the presence of nocodazole, greater than 90% of cells were eGFP positive 24 h post-transfection and qSEAP was increased almost fivefold, doubling total SEAP production. Under optimal conditions for PEI-mediated transfection, transient production of a recombinant chimeric IgG4 encoded on a single vector was enhanced twofold by nocodazole, a final yield of approximately 5 microg mL(-1) achieved at an initial viable cell density of 1 x 10(6) cells mL(-1). The glycosylation of the recombinant antibody at Asn297 was not significantly affected by nocodazole during transient production by this method.


Subject(s)
DNA/administration & dosage , Drug Delivery Systems/methods , Immunoglobulin G/biosynthesis , Nocodazole/administration & dosage , Polyethyleneimine/chemistry , Protein Engineering/methods , Transfection/methods , Animals , Antineoplastic Agents/administration & dosage , CHO Cells , Cricetinae , Cricetulus , DNA/chemistry , DNA/genetics , Gene Targeting/methods , Genetic Enhancement/methods , Immunoglobulin G/genetics , Microtubules/drug effects , Pharmaceutical Vehicles/chemistry , Recombinant Proteins/biosynthesis
12.
Biochem Biophys Res Commun ; 306(4): 1050-5, 2003 Jul 11.
Article in English | MEDLINE | ID: mdl-12821149

ABSTRACT

The relationship between spot volume and variation for all protein spots observed on large format 2D gels when utilising silver stain technology and a model system based on mammalian NSO cell extracts is reported. By running multiple gels we have shown that the reproducibility of data generated in this way is dependent on individual protein spot volumes, which in turn are directly correlated with the coefficient of variation. The coefficients of variation across all observed protein spots were highest for low abundant proteins which are the primary contributors to process error, and lowest for more abundant proteins. Using the relationship between spot volume and coefficient of variation we show it is necessary to calculate variation for individual protein spot volumes. The inherent limitations of silver staining therefore mean that errors in individual protein spot volumes must be considered when assessing significant changes in protein spot volume and not global error.


Subject(s)
Electrophoresis, Gel, Two-Dimensional/methods , Proteins/analysis , Reproducibility of Results , Animals , Cell Line , Mice , Silver Staining
13.
Biotechnol Prog ; 19(1): 121-9, 2003.
Article in English | MEDLINE | ID: mdl-12573014

ABSTRACT

To increase transient expression of recombinant proteins in Chinese hamster ovary cells, we have engineered their protein synthetic capacity by directed manipulation of mRNA translation initiation. To control this process we constructed a nonphosphorylatable Ser(51)Ala site-directed mutant of eIF2alpha, a subunit of the trimeric eIF2 complex that is implicated in regulation of the global rate of mRNA translation initiation in eukaryotic cells. Phosphorylation of eIF2alpha by protein kinases inhibits eIF2 activity and is known to increase as cells perceive a range of stress conditions. Using single- and dual-gene plasmids introduced into CHO cells by electroporation, we found that transient expression of the eIF2alpha Ser(51)Ala mutant with firefly luciferase resulted in a 3-fold increase in reporter activity, relative to cells transfected with reporter only. This effect was maintained in transfected cells for at least 48 h after transfection. Expression of the wild-type eIF2alpha protein had no such effect. Elevated luciferase activity was associated with a reduction in the level of eIF2alpha phosphorylation in cells transfected with the mutant eIF2alpha construct. Transfection of CHO cells with the luciferase-only construct resulted in a marked decrease in the global rate of protein synthesis in the whole cell population 6 h post-transfection. However, expression of the mutant Ser(51)Ala or wild-type eIF2alpha proteins restored the rate of protein synthesis in transfected cells to a level equivalent to or exceeding that of control cells. Associated with this, entry of plasmid DNA into cells during electroporation was visualized by confocal microscopy using a rhodamine-labeled plasmid construct expressing green fluorescent protein. Six hours after transfection, plasmid DNA was present in all cells, albeit to a variable extent. These data suggest that entry of naked DNA into the cell itself functions to inhibit protein synthesis by signaling mechanisms affecting control of mRNA translation by eIF2. This work therefore forms the basis of a rational strategy to generically up-regulate transient expression of recombinant proteins by simultaneous host cell engineering.


Subject(s)
CHO Cells/metabolism , Gene Expression Regulation/genetics , Protein Engineering/methods , RNA, Messenger/genetics , Recombinant Proteins/biosynthesis , Transfection/methods , Animals , CHO Cells/physiology , Cricetinae , Electroporation/methods , Eukaryotic Initiation Factor-2/biosynthesis , Eukaryotic Initiation Factor-2/genetics , Eukaryotic Initiation Factor-2/metabolism , Luciferases/biosynthesis , Luciferases/genetics , Mutagenesis, Site-Directed/genetics , Plasmids/administration & dosage , Protein Biosynthesis/genetics , Recombinant Proteins/genetics
SELECTION OF CITATIONS
SEARCH DETAIL
...